New Warfarin PGx Study Will Test New Dosing Algorithms, Aim to Avoid Criticisms of Past Trials

The Genetics Informatics Trial of Warfarin will apply new PGx algorithms to investigate the utility of genetic testing in the orthopedic population.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories